GlassScriptPhysician profile
Maxwell A Prempeh
NPI 1992867592
$46,735.39
in general payments reported to CMS, 2019-2025
44 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,791 · 2020: $5,407 · 2021: $6,688 · 2022: $8,555 · 2023: $13K · 2024: $3,445 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,580 · Food and Beverage: $7,156 · Travel and Lodging: $1,309 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,580.00 |
| Food and Beverage | $7,156.20 |
| Travel and Lodging | $1,308.52 |
| Education | $249.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $35,063.15 | 2019-2025 | Uptravi, Opsumit |
| Abbott Laboratories | $1,910.91 | 2019-2025 | Optis, Xience Skypoint, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,562.17 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,087.64 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $596.40 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $577.15 | 2019-2024 | Farxiga, Lokelma, Brilinta |
| Shockwave Medical, INC | $559.89 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Amgen INC. | $537.74 | 2019-2025 | Repatha |
| Boston Scientific Corporation | $498.09 | 2019-2025 | General - Balloon Catheters, Avvigo Guidance System, Watchman Access System |
| Merck Sharp & Dohme LLC | $429.63 | 2022-2025 | Verquvo, Winrevair |
| Bayer Healthcare Pharmaceuticals INC. | $387.32 | 2019-2025 | |
| Cvrx, INC. | $364.73 | 2024 | Barostim Neo System |
| Pfizer INC. | $314.82 | 2019-2024 | |
| Lexicon Pharmaceuticals, INC. | $286.57 | 2023-2024 | Inpefa |
| United Therapeutics Corporation | $240.51 | 2022-2024 | Tyvaso, Orenitram, Remodulin |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $188.75 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Gilead Sciences, INC. | $173.34 | 2019-2025 | |
| Penumbra, INC. | $157.87 | 2025 | Indigo System |
| Amarin Pharma, INC. | $156.96 | 2019-2020 | |
| Philips North America LLC | $147.02 | 2019-2024 | (Ck4) Mcot |
| Medtronic, INC. | $143.55 | 2021-2023 | Onyx Frontier |
| W. L. Gore & Associates, INC. | $140.26 | 2020-2025 | Gore Cardioform Septal Occluder |
| Abiomed | $139.47 | 2022-2025 | |
| Heartflow, INC. | $118.95 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $117.89 | 2019-2024 | Eliquis, Camzyos |
| Recor Medical INC | $103.35 | 2024 | Paradise Renal Denervation System |
| Sanofi-Aventis U.S. LLC | $101.64 | 2019-2023 | |
| Esperion Therapeutics, INC. | $83.89 | 2022-2024 | Nexletol |
| Livanova USA, INC. | $77.57 | 2021 | |
| Impulse Dynamics (USA) INC. | $76.22 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.75 | 2019-2024 | Jardiance |
| Stryker Corporation | $42.99 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $42.82 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $41.95 | 2024 | Rybelsus, Ozempic |
| Medtronic Vascular, INC. | $38.22 | 2020 | |
| Terumo Medical Corporation | $24.75 | 2025 | Tr Band, Angio-Seal |
| Kiniksa Pharmaceuticals International, Plc | $21.51 | 2024 | Arcalyst |
| Acist Medical Systems, INC. | $20.29 | 2024 | |
| Lantheus Medical Imaging, INC. | $19.75 | 2024 | |
| Cardinal Health 200 LLC | $19.16 | 2021 | |
| Cordis US Corp. | $18.25 | 2023 | Radial 360 |
| Ge Healthcare | $18.05 | 2019 | |
| Chiesi USA, INC. | $17.36 | 2025 | Cleviprex, Kengreal |
| Astellas Pharma US INC | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maxwell Prempeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.